GlassScriptPhysician profile
Jafar Golzarian
NPI 1093703944
$501,246.76
in general payments reported to CMS, 2019-2025
35 companies · $60K in 2025
The $60K reported for 2025 was more than what 97% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $34K · 2021: $39K · 2022: $201K · 2023: $42K · 2024: $86K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Acquisitions: $17K · Food and Beverage: $8,193 · Travel and Lodging: $5,486 · Honoraria: $3,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,857.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,468.00 |
| Acquisitions | $16,802.70 |
| Food and Beverage | $8,192.67 |
| Travel and Lodging | $5,486.19 |
| Honoraria | $3,900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $235,058.44 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, General - Embolics, General - Interventional Oncology |
| Ge Healthcare | $55,794.34 | 2023-2025 | Allia |
| Penumbra, INC. | $46,643.05 | 2019-2025 | Ruby Coil, Indigo System, Penumbra System |
| Medtronic, INC. | $38,311.70 | 2021-2025 | Onyx 18, Concerto Versa, Abre |
| Terumo Medical Corporation | $23,430.43 | 2019-2025 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Medtronic Vascular, INC. | $19,359.95 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $13,225.54 | 2019-2024 | Embozene, Varian Cryocare Touch System |
| Balt USA, LLC | $12,620.71 | 2021 | |
| Varian Medical Systems, INC. | $11,470.11 | 2019-2020 | |
| Sirtex Medical INC | $10,603.68 | 2019-2025 | Sir-Spheres Microspheres |
| Instylla, INC. | $8,800.00 | 2025 | |
| Okami Medical, INC. | $8,640.04 | 2022-2025 | Lobo |
| Heraeus Medical Components, LLC | $3,617.63 | 2019-2021 | |
| Asahi Intecc USA, INC. | $3,326.94 | 2024-2025 | Asahi Interventional Radiology Wires, Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Bard Peripheral Vascular, INC. | $3,072.10 | 2021-2025 | Liverty, Venovo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $3,050.00 | 2024 | Cook |
| Mediview Xr, INC. | $1,400.00 | 2023 | |
| Guerbet LLC | $673.50 | 2021 | |
| Shape Memory Medical INC. | $666.19 | 2019-2021 | |
| Merit Medical Systems INC | $365.01 | 2022-2025 | Merit Meastro Microcatheters, Embosphere Microspheres |
| Argon Medical Devices, INC. | $342.68 | 2019-2025 | Clot Management, Clot Management |
| Biocompatibles, INC. | $185.98 | 2019 | |
| Atricure, INC. | $178.37 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Angiodynamics, INC. | $156.37 | 2022 | |
| Organogenesis INC. | $64.13 | 2025 | Cygnus Dual, Puraply Wound Matrix |
| Btg International Canada INC. | $47.06 | 2019 | |
| Histosonics, INC. | $23.11 | 2025 | |
| Trisalus Life Sciences, INC. | $22.29 | 2024 | Trinav Infusion System |
| W. L. Gore & Associates, INC. | $18.47 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Smith+Nephew, INC. | $17.72 | 2025 | Collagenase Santyl |
| Cook Medical LLC | $16.66 | 2023 | Zilver Ptx |
| Cordis US Corp. | $15.19 | 2024 | Mynxgrip |
| Inari Medical, INC. | $14.25 | 2021 | |
| Heraeus Medical, LLC. | $8.32 | 2021 | |
| Abk Biomedical USA, INC. | $6.80 | 2025 | Eye90 Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$550.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$15,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jafar Golzarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.